Indian Journal of Pharmacy and Pharmacology

Print ISSN: 2393-9079

Online ISSN: 2393-9087

CODEN : IJPPTK

Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 662

PDF Downloaded: 373


Get Permission Mohamed Aamir Zuhaib S, John, Sunitha M, and Chandy: An overview on prophylactic antibiotics in operative patients to combat post-surgical complications


Introduction

Antibiotics are the class of medications intended to treat and prevent bacterial infections by predominantly acting on bacteria by either making it difficult for the organism to grow and multiply or by killing them.1 They play a major role in the recent modern healthcare in improving the patient's health outcomes mainly in the areas of medicine or surgery, chronic conditions, Diabetes mellitus, end-stage renal disease, rheumatoid arthritis, organ transplants, or cardiac surgeries.2 The antimicrobial agents are classed based on their pharmacology and in vitro effects into 2 major brackets: bactericidal and bacteriostatic. The bacteriostatic drugs ''kill'' the bacterial growth, has an MBC to MIC ratio of more than 4, and the bacteriostatic drugs that "retards the growth", have an MBC to MIC ratio less than or equal to 4. Further, to accurately group each category, criteria such as minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) must be clearly known. The minimum inhibitory concentration can be defined as the lowest concentration of an antimicrobial that shows a visible inhibition of bacterial growth within 24 hours. And, minimum bactericidal concentration is the concentration of the agent that causes a 1000-fold reduction of bacterial density within 24 hours.3, 4 In surgical procedures, a prophylactic antibiotic indicates an antimicrobial agent that is administered in patients who have no established infections, which is further beneficial in preventing surgical site infections and other infections.5 Prophylactic antibiotics should be administered intravenously to patients undergoing surgery. But, the choice of antibiotic, dose, and frequency of the regimen need further clarity. An efficient regimen can be beneficial in improving the health status of the patient which further reduces the economic burden on the patient.6, 7

The main aim of this literature review is to provide information on the importance of prophylaxis in different surgical departments, the timing of prophylaxis, incision time after administration, and the recent trends that are practised in surgery.

Appropriate Prophylactic Antibiotic Selection

The correct choice of the prophylactic agent is crucial in achieving the desired therapeutic outcome. In various animal studies and scientifically controlled clinical studies, the importance of prophylaxis against postoperative complications has been elucidated.8 Certain standard measures have to be noted in selecting the right antibiotic therapy which include: The anatomic site of the surgery. The spectrum of activity of the antimicrobial; and the pharmacokinetic parameters. Some criteria have to be also taken into consideration with the above ones which include: resistance to the drug, possible interaction of the drug with other drugs, toxicity, and economic factors. Due to the irrational use of antibiotics, there is a rapid increase in the resistance to antimicrobial agents. In recent times, the use of broad-spectrum beta-lactam agents for surgical prophylaxis is not commended. The appropriate choice of Antibiotic prophylaxis is also dependent on multi-drug resistance, allergic reaction and the rate of infection. Clean contaminated surgical procedures and prosthesis insertion are the classic reasons for antibiotic prophylaxis. The NRC (National Research Council) has devised a 4-classification system which describes wounds. It is classified as clean, clean-contaminated, contaminated and dirty. For each of the above classes of the wound, the infection rates respectively are; <2%, 5-15%, and >30%.9, 10 The main basis of this classification was the density of bacteria in the wound. Certain other factors that could be associated with an increased degree of post-operative infection include; weight reduction, depletion of protein, physiological dysfunction of an organ system, and overall poor health of the subject.11 The increased mortality in patients undergoing surgery is associated with inappropriate or delayed antibiotic treatment. Therefore, the intravenous antibiotic regimen should have a broad-spectrum activity that covers all the likely infectious pathogens.12 Generally for serious infections and major surgeries, potent antibiotics are not preferred to be used. To achieve the effective and maximum level of the drug in the serum and tissues during and after the incision, the maximum concentration of the prophylactic antibiotic should be administered preoperatively.13, 14

Timing and Duration of Prophylactic Antibiotic

The timing of the antibiotic for surgical patients plays a major role in better treatment outcomes. The timing of antibiotic administration was classified into four categories15 and is depicted (Table 1). In the studies performed it was found that there was a considerable reduction in the incidences of surgical site infections when the prophylaxis was administered within 2 hours before surgery16 whereas to avoid the chances of intra-operative contamination, it was found that an effective tissue concentration should be maintained which is achieved by administering the prophylactic antibiotics 30 mins prior the skin incision.17 It should be noted that when the antibiotic is administered postoperatively in the recovery room, it might not show to be effective due to a combination of factors that prevent antibiotic delivery. These factors include vasoconstriction, thrombosis, and separation of wounds from the vascular systems which causes an inflammatory response. Effective serum tissue levels will not be achieved at lower levels. The majority of antibiotics administered as prophylaxis have a half-life of fewer than 2 hours, continuing the antibiotic regimen beyond the day of operation is neither beneficial nor reduces the risk of developing postoperative infections.18, 19 In some cases the frequency of dosing is 2-4 hours intraoperatively even when the blood loss exceeds 1000ml.18 Various studies have assessed the optimal duration of antibiotic prophylaxis peri operatively and suggested short term perioperative antibiotic regimen is as effective as long-term in the prevention of postoperative complications.20 However long-term prophylaxis in certain cases can induce bacterial resistance that could vary from an individual patient and affect the clinical outcome.21

Table 1

Administration time of antibiotics`15

Administration time

Category

2 - 4 hours before skin incision

Early prophylaxis

2 hours before skin incision

preoperative prophylaxis

3 hours after skin incision

peri-operative prophylaxis

3 - < 24 hours after skin incision

post operative prophylaxis

Areas of Concern

Surgical site infection

Surgical site infections are the infections that develop and persist within 30 days of a surgical procedure in cases where there is no placement of an implant and within one year in cases of insertion of an implant.22 They are the most frequently seen major serious post-operative complication seen in surgical patients. In a survey performed by TG Emori et al, according to the National Nosocomial Infections Surveillance (NNIS) system, it was reported that SSIs account for 12-16% of the major nosocomial infections among hospitalized patients.23 SSI can have further effects on the patient and healthcare like increased antibiotic prescribing rate, and economic burden on the patients like laboratory costs. The patients who were found to have an infection rate of 60% were more likely to be admitted to the ICU, 5% more likely to be readmitted, they had a 2% higher mortality rate as compared to the non-infected people. Another interesting fact is that 40-60% of these infections are well preventable.24 In a study performed by HH Stone et al; on antibiotic prophylaxis, it was concluded that the administration of antibiotics within 2 hours of any surgery had the lowest occurrence of surgical wound infection which was further supported by the logistic regression analysis. SSI can be considered as the index of the health care system in any hospital. It can be concluded that the time of antibiotic administration is inversely proportional to the incidences of wound infection.25 The major organisms causing these include gram-positive cocci predominantly staphylococci, even though gram-negative bacteria are also involved. Therefore, when compliance with the antibiotic policies is followed, an overall improvement in the rate of patient wound infection can be seen.26

Adverse Drug Reaction

Whenever an exogenous product is administered into the body, it has a potential for developing an adverse reaction and antibiotics also have a similar property.27 Every 5 patients in a hospital who are on antibiotics have been shown to develop such reactions. A survey on adverse events from the National Electronic Injury Surveillance System concluded that a major population of emergency department visits were due to an adverse reaction due to an antibiotic.28 An adverse event should be clear foreseen when initiating any therapy, especially antibiotic therapy. The most susceptible population include paediatrics, geriatrics, immunocompromised patients, patients with other co-morbidities and hospitalized patients.29 Therefore, it is very crucial to monitor if the patient uses higher class antibiotics and check the compliance with the standard policies of patients on antibiotic regimen especially on the prophylactic and empirical antibiotics in surgical patients for better therapeutic outcomes.30

Antimicrobial Resistance

A major area that requires attention due to the misuse and overuse of antibiotics when not under physicians' vigilance is antibiotic resistance. Due to the emergence and dissemination of resistance by bacterial pathogens, the efficacy of antibiotics has been altered. Certain pathogens such as Staphylococcus Aureus, Enterococcus spp., Pseudomonas aeruginosa along with some gram-negative become to all available antibiotics therapy. This leads to totally drug-resistant phenotypes causing an "antibiotic resistance crisis".31 Bacteria have a short growth cycle and evolve very rapidly in the environment, which enables them to live through harsh and unfavourable conditions.32 For many decades Methicillin-resistant S. aureus (MRSA), has been a major pathogen causing an antibiotic crisis which has a major effect on the clinical outcomes versus the methicillin-susceptible S. aureus.32, 33, 34 MRSA has the highest prevalence in Asia among all the other continents.35, 36 Generally, a higher MIC value above the susceptibility threshold can be concluded as antibiotic resistance. The resistance that occurs can have either intrinsic or acquired properties. All the available antibiotic classes of medications cannot act on all the various bacterial pathogens. Intrinsic resistance is termed when the bacteria do not have the target regions for antibiotic activity.37 In cases where the pathogen acquires resistance from the genes of other bacteria or due to gene mutation, it leads to reduced antibiotic efficacy, which can be termed acquired resistance.37 Vancomycin, a glycopeptide antibiotic which is often a drug of choice in treating the infections associated with MRSA for the last 7 years, shows that there is an increase in the incidence of vancomycin-intermediate S. aureus (VISA) and Vancomycin-resistant S. aureus (VRSA).38 The inappropriate antibiotic prescribing pattern is a major contributing factor in the emergence of resistance.10 Studies have also shown that in 30% and 50% of the cases, there is an inappropriate choice of an antibiotic, or false treatment indication.39 The misuse and overuse of antibiotics lead to the development of resistance to all the antibiotic treatment modalities that cause the development of multi-drug resistant strains called "super-bugs".40 These above factors influence the emergence of antimicrobial resistance which is a growing public health issue and requires appropriate awareness to promote the rational use of antibiotics.

Septicemia

Sepsis is one of the most dangerous post-operative complications observed. When an adequate antimicrobial prophylaxis has been administered, there is a lower rate of mortality among patients with gram-negative bacteraemia and other rate of infections.41, 42, 43 Sepsis is defined as, the aggravated, inappropriate immune systemic immune response to the infection which is associated with organ dysfunction, hypoperfusion or hypotension.44 This further creates a drastic burden on the healthcare system and economic burden. In a survey performed by Martin et al it was found that the number of sepsis related cases are increasing.45 As per reports, this post operative infection still remains the leading cause of death in the U.S and one in three persons with sepsis are due to Surgical procedures.46 The occurrence of sepsis is dependent on many factors which includes race, age, size of the hospital and the economic status of the patient. Furthermore, the evaluation of the surgical procedure, the patient population may help the associated complication.47 The biochemical studies and genetic markers help in better diagnosis which may further prevent chances of mortality.48 An appropriate antibiotic prophylaxis treatment is an important determinant of survival. Thus, an inappropriate antibiotic treatment was associated with increased mortality where, the efficiency of the therapy is independent of the rate of survival in comparison with immunomodulatory properties.40

Prophylaxis in Cardiac Surgery

As a routine practice, prophylactic antibiotics are generally administered to patients undergoing any type of cardiac surgical procedure.48 But, the preferred choice of drug, dosage and frequency of the operative regimen is still under discussion. There is much evident morbidity, mortality and economic burden on the patient when nosocomial infections persist after surgery.49 Hence, there are standard clinical practice guidelines that have been created that give the data on the choice of drug, duration, dose, frequency and therapy in case of predicted sepsis. The majority of the studies have shown that after the wound closure, the surgical prophylaxis is not needed and when single-dose studies were compared with double-dose antibiotic regimens, they did not show any further efficiency.50 However, in recent times the guidelines have shown the importance of an elaborated prophylactic regimen in case of cardiac surgery like cardiopulmonary bypass, invasive devices after surgery, bleeding requiring blood transfusion and delayed extubation after a procedure. There are no sufficient data available on the pharmacokinetic parameters of antibiotics in cardiopulmonary bypass hence it is generally administered based on experience and historical practice.51 Cardiac surgery has an increased chance of showing a high rate of systemic inflammatory response. The degree of this inflammatory response in an individual patient, and sometimes can be very harmful to the patient52 In cardiothoracic surgery, it is recommended that all patients should be given prophylaxis and the antibiotics class of choice is first-or second-generation cephalosporin (cefazolin or cefuroxime)53 Macrolides such as Clindamycin is used in cases of allergy to beta-lactams and vancomycin is used in cases of infection with methicillin-resistant staphylococcus aureus. The duration of the prophylaxis given should not be more than 48 hours; the skin incision should be done within 0.5 to 2 hours of the procedure. However, this timing can vary with the standard policies of other countries.54 With regards to the choice of the antimicrobial agent, second-generation cephalosporins are more preferred compared to the other class of antibiotics, because they exhibit broad-spectrum activity and act on both the gram-negative and gram-positive pathogens. Further, they have a good safety with comparatively lesser side effects and can also be given to patients with penicillin allergies. But, the use of cephalosporins with Clostridium difficile infection is not well pronounced.55 Recent studies have shown that there is an increasing trend in prescribing second-generation cephalosporins in cardiac surgeries due to their safety and efficacy profile.56, 57

Prophylaxis In Gastroenterology Surgery

The prophylactic antibiotics in the case of gastroenterology are based on criteria such as the type of gastrointestinal infection, the non-classic gastrointestinal disease that does not involve an infectious agent, and prophylaxis for gastrointestinal procedures. There are variety of classes of antibiotics, hence the appropriate selection of the antibiotics is focused on here.58 In the case of Bacterial Diarrhoea, the main focus of treatment is rehydration and other non-pharmacological management. Antibiotic treatment is recommended in case of shigellosis, cholera, and Clostridium difficile diarrhoea. Among the newer generation of antibiotics, fluoroquinolones have a broader spectrum of activity except Clostridium difficile.59 with the increase in the incidence of antibiotic resistance to drugs such as ampicillin and trimethoprim-sulfamethoxazole, quinolones have become the most preferred class of antibiotic in the management of diarrhoea. This is also associated with the management of Salmonella typhi infections. 60, 61 In case of relapsing Clostridium difficile infections, vancomycin in combination with rifampin is recommended.62 There is not much-documented data on the infections due to endoscopy. But fatal infections have been reported after surgical procedures63 While administering the antibiotics, certain criteria such as the nature of the organism, and the efficacy of the antibiotic administered should be taken into consideration. Other host factors that could also possibly increase the chance of infection include any cardio-vascular abnormalities, presence of prosthetic devices and immunocompromised state.64, 65 The recent practices for the prophylaxis are based on extrapolations from various data on the risk of bacteraemia66 The major indications for antibiotic prophylaxis, include bacterial endocarditis, cholangitis or sepsis due to (ERCP) Endoscopic retrograde cholangiopancreatography and wound infections with PEG. The administration of prophylaxis is also recommended in procedures involving immunocompromised patients undergoing bone marrow transplantation and patients with the presence of neutropenia.67, 68

Prophylaxis In Neurosurgery

The administration of a prophylactic antibiotic is the standard clinical practice before any neurosurgery. As per clinical studies, important criteria that should be taken into consideration include, the patient’s immune system, the nature of the pathological organisms and the nature of surgery. Intravenous first and second generation of cephalosporins are most commonly used and in case of allergy, vancomycin is recommended.69 In a survey performed by Mazda KT et al. on the prophylactic use of antibiotics in neurosurgery, it was found that a single dose of antibiotic was used for about 85% of the cranial surgeries. It was also found that, cephalosporins (alone or in combination) from different generations was about 89.8%, 97% in cranial surgeries.70 When many parameters like cost of the therapy, economic status of the patient, drug toxicological parameters, and the duration of the antibiotic therapy cefazolin is generally recommended in case of clean neurological surgery.71

Prophylaxis In Obstetrics and Gynaecology

SSIs are one of the most common complications associated with patients undergoing surgery. In gynaecological surgical patients it has a prevalence of 8-10% and the rate of infection varies from every individual patient depending on condition of the patient as well as surgical factors72, 73 Generally in case of obstetric or gynaecological surgeries, multiple doses of the antibiotic is not recommended apart from the initial dose of the drug which includes the anaesthetic regimen. Further, studies performed on multiple doses of the antibiotic show no differences compared to the single dose of the drug.74, 75 Preferably, the prophylactic antibiotic administered should be narrow spectrum in order to avoid chances of resistance.76 Before every surgical procedure, it is very important to consider the source of pathogens. For majority of the obstetrics or gynaecological procedures, the source of pathogens is endogenous in nature present in the vagina or skin. The flora of the genital tract in women is polymicrobial, presence of anaerobes, gram-negative aerobes and gram-positive cocci. Further, in comparison with laparoscopic procedures where there is no mucosal surface and more chances of skin contamination only. While administering the antibiotic, the drug administered need not cover all the nature of the pathogens. Narrow spectrum cephalosporins are used more often in contrast to the second and third generation antibiotics because they have shown more incidences of antibiotic resistance and have less activity against Staphylococci.77 The women undergoing C-section surgeries have more risk of developing infection compared to the women delivering vaginally.78 Recent studies have shown that women undergoing C-Section surgery should be adequately administered with a surgical prophylaxis. A single dose of the antibiotic is generally administered within 30 minutes before the surgery.79 The prevalence of infection in the first trimester of pregnancy is from 0.01 to 2.44% and there is a similar rate of prevalence in the second trimester also,80, 81 Both oral doxycycline and metronidazole is beneficial in reducing the risk of post-abortal infection,82 In procedures such as hysterectomy, it has been well established that for both vaginal and abdominal hysterectomy, the antibiotic prophylaxis benefits reduce post-operative infection.83, 84 When a randomised non-blinded controlled trial was performed on women with bacterial vaginosis, it was seen that there was a significant reduction in the rate of vaginal cuff infection in post-hysterectomy patient on treatment with rectal metronidazole.85 But, for certain low risk obstetrics and gynaecological procedures, such as laparoscopy, IUD or medical termination of pregnancy (MTP) does not require the administration of antibiotics.

Conclusion

In conclusion, it was found that surgical prophylaxis administered prior to surgery improves the treatment outcomes which is beneficial in the prevention of post-surgical complications. Further, the selection of the appropriate antibiotic is based on the cost, and the pharmacokinetic parameters including half-life, toxicity parameters, antimicrobial resistance, effectiveness and safety profile. In the case of major surgeries like cardiac surgery, gastric surgery, vascular surgery, obstetrics and gynaecological surgeries, the prophylaxis should be given 30-60 minutes before the incision time. However, the prophylactic antibiotic should be given 2 hours prior in case of neurosurgery and the antibiotic chosen should have a longer half-life in order to maintain the tissue levels during the entire procedure. Cephalosporins which are a broad-spectrum class of antibiotics are the most preferred class of drugs in major surgeries due to their bioavailability, half-life and safety parameters. Moreover, resistance to antimicrobials because of irrational use of antibiotics is an area of concern in recent times and adequate measures should be taken to reduce the unnecessary overuse and limit the spread of resistance. From this review, it was found that when suitable prophylaxis was administered there is a significant reduction in the rate of surgical site infections as well as other post-surgical complications. Thus, the prophylactic antibiotic administration long with appropriate post-operative care has proved a potent role in uneventful surgeries.

Abbreviations

SSI Surgical Site Infection; MBC - Minimum Bactericidal Concentration; MIC – Minimum Inhibitory Concentration; NRC – National Research Council; NNIS – National nosocomial Infections Surveillance; ICU – Intensive Care Unit; MRSA – Methicillin Resistant Staphylococcus aureus; VISA – Vancomycin Intermediate Staphylococcus aureus; VRSA – Vancomycin Resistant Staphylococcus aureus; ERCP – Endoscopic Retrograde Cholangiopancreatography; PEG – Percutaneous Endoscopic Gastrostomy; IUD – Intrauterine Device; MTP – Medical Termination Of Pregnancy.

Source of Funding

None.

Conflict of Interest

None.

References

1 

C Calhoun H Wermuth G Hall AntibioticsOnline] Ncbi.nlm.nih.gov. Available2022

2 

I M Gould A M Bal New antibiotic agents in the pipeline and how they can help overcome microbial resistance. Virulence20134218591

3 

G A Pankey L D Sabath Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections.Clin Infect Dis200438686470

4 

K Y Rhee D F Gardiner Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infectionsClin Infect Dis200438675561

5 

K A Ludwig M A Carlson R E Condon Prophylactic antibiotics in surgery. Annual Rev Med19934438593

6 

I Lola S Levidiotou A Petrou H Arnaoutoglou E Apostolakis G S Papadopoulos Are there independent predisposing factors for postoperative infections following open heart surgery? Journal of cardiothoracic surgery2011619

7 

F H Edwards R M Engelman P Houck D M Shahian C R Bridges The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part I: duration. The Annals of thoracic surgery200681397404

8 

H C Polk J F Lopez-Mayor Postoperative wound infection: a prospective study of determinant factors and preventionSurgery196966197103

9 

C P Page J M Bohnen J R Fletcher A T Mcmanus J S Solomkin D H Wittmann Antimicrobial prophylaxis for surgical wounds: guidelines for clinical care. Arch Surg199312817988

10 

Office of Infectious Disease Antibiotic resistance threats in the United States2013http://www.cdc.gov/drugresistance/threat-report-2013.Accessed

11 

R L Nichols Surgical wound infectionAm J Med19919135464

12 

A Lador H Nasir N Mansur E Sharoni P Biderman L Leibovici Antibiotic prophylaxis in cardiac surgery: systematic review and meta-analysisJ Antimicrob Chemother201267354150

13 

K A Ludwig M A Carlson R E Condon Prophylactic Antibiotics In SurgeryAnn Rev Med19934438593

14 

D W Burdon Principles of antimicrobial prophylaxisWorld J Surg1982632629

15 

D C Classen R S Evans S L Pestotnik S D Horn R L Menlove J P Burke The timing of prophylactic administration of antibiotics and the risk of surgical-wound infectionNew England J Med199232652817

16 

M Shapiro T R Townsend B Rosner E H Kass Use of antimicrobial drugs in general hospitals: patterns of prophylaxisNew England J Med197930173516

17 

R E Condon D H Wittmann The use of antibiotics in general surgeryCurrent Problems Surg1991281807907

18 

D P Alexander J M Becker Cefoxitin disposition in colorectal surgery. Implications for the effective use of prophylactic antibiotics.Annals Surg198820811628

19 

H H Stone B B Haney L D Kolb C E Geheber C A Hooper Prophylactic and preventive antibiotic therapy: timing, duration and economics. Ann Surg197918966918

20 

D W Bratzler P M Houck Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention ProjectClin Infect Dis2004151170621

21 

L G Bode J A Kluytmans H F Wertheim D Bogaers C M Vandenbroucke-Grauls R Roosendaal Preventing surgical-site infections in nasal carriers of staphylococcus aureusNew England J Med20103621917

22 

A Kumar A Rai Prevalence of surgical site infection in general surgery in a tertiary care centre in IndiaInt Surg J20174931017

23 

T G Emori R P Gaynes An overview of nosocomial infections, including the role of the microbiology laboratory.Clin Microbiol Rev19936442870

24 

A J Mangram T C Horan M L Pearson L C Silver W R Jarvis Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection199924780

25 

H H Stone C A Hooper L D Kolb C E Geheber E J Dawkins Antibiotic prophylaxis in gastric, biliary and colonic surgery.Ann Surg1976184443

26 

J P Kirby J E Mazuski Prevention of surgical site infection. Surg Clin North Am200989236589

27 

P D Tamma E Avdic D X Li K Dzintars S E Cosgrove Association of adverse events with antibiotic use in hospitalized patientsJAMA Internal Med20171779130823

28 

N Shehab P R Patel A Srinivasan D S Budnitz Emergency department visits for antibiotic-associated adverse events.Clinical Infect Dis200847673578

29 

P D Tamma E Avdic D X Li K Dzintars S E Cosgrove Association of adverse events with antibiotic use in hospitalized patientsJAMA Int Med20171779130823

30 

T J Lynch Choosing optimal antimicrobial therapies.Med Clin2012966107994

31 

G M Rossolini F Arena P Pecile S Pollini Update on the antibiotic resistance crisis.Curr Opin Pharm2014185660

32 

World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report2021https://apps.who.int/iris/bitstream/handle/10665/341666/9789240027336-eng.pdf

33 

H Hanberger S Walther M Leone P S Barie J Rello J Lipman Increased mortality associated with meticillin-resistant Staphylococcus aureus (MRSA) infection in the Intensive Care Unit: results from the EPIC II studyInt J Antimicrob Agents20113843316

34 

K Weist L D Högberg ECDC publishes 2015 surveillance data on antimicrobial resistance and antimicrobial consumption in EuropeEurosurveillance2016214630401

35 

S J Van Hal T P Lodise D L Paterson The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysisClin Infect Dis201254675571

36 

Y Y Chuang Y C Huang Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Asia. Lancet Infect Dis201313698708

37 

L F Chen T Chopra Ks ; Kaye L F Chen T Chopra K S Kaye Pathogens resistant to antibacterial agentsMed Clin201195464776

38 

H K Tiwari M R Sen Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.BMC Infect Dis2006616

39 

C E Luyt N Bréchot J L Trouillet J Chastre Antibiotic stewardship in the intensive care unitCritical care201418512

40 

P T Alpert Superbugs: antibiotic resistance is becoming a major public health concern.Home Health Care Manag Pract20172911303

41 

M P Weinstein M L Towns S M Quartey The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adultsClin Infect Dis1997244584602

42 

M H Kollef Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patientsClin Infect Dis20003141318

43 

M S Niederman Appropriate use of antimicrobial agents: challenges and strategies for improvementCrit Care Med200331260816

44 

R C Bone R A Balk F B Cerra R P Dellinger A M Fein W A Knaus Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsisChest19921016164489

45 

G S Martin D M Mannino S Eaton M Moss The epidemiology of sepsis in the United States from 1979 throughNew England J Med20001716154654

46 

R N Anderson B L Smith Deaths: leading causes for 2002. National vital statistics reports2005189

47 

T R Vogel V Y Dombrovskiy J L Carson A M Graham S F Lowry Postoperative sepsis in the United States. Ann Surg20102526106571

48 

A Gorski K Hamouda M Özkur M Leistner S P Sommer R Leyh Cardiac surgery antibiotic prophylaxis and calculated empiric antibiotic therapy.Asian Cardiovascular Thoracic Ann201523128290

49 

K Reinhart F M Brunkhorst H E Bone J Bardutzky C E Dempfle H Forst Prevention, diagnosis, treatment, and follow-up care of sepsis. First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI)Der Anaesthesist201059434770

50 

S I B Torres C A Umscheid D W Bratzler B Leas E C Stone R R Kelz Centers for disease control and prevention guideline for the prevention of surgical site infectionJAMA Surg2017152878491

51 

R Kappeler M Gillham N M Brown Antibiotic prophylaxis for cardiac surgeryJ Antimicrobial chemother20126735213

52 

S G Raja G D Dreyfus Modulation of systemic inflammatory response after cardiac surgery. Asian Cardiovascular Thoracic Ann200513438295

53 

L Zhou J Ma J Gao S Chen J Bao Optimizing prophylactic antibiotic practice for cardiothoracic surgery by pharmacists’ effectsMedicine201695977780

54 

Y Kato N Shime S Hashimoto M Nomura Y Okayama M Yamagishi Effects of controlled perioperative antimicrobial prophylaxis on infectious outcomes in pediatric cardiac surgery. Crit care Med2007351176371

55 

A Gupta M P Hote M Choudhury A Kapil A K Bisoi Comparison of 48 h and 72 h of prophylactic antibiotic therapy in adult cardiac surgery: a randomized double blind controlled trialJ Antimicrob Chemother2010655103677

56 

S Nooyen B P Overbeek A B Rivière Prospective Randomised Comparison of Single-Dose versus Multiple-Dose Cefuroxime for Prophylaxis in Coronary Artery Bypass GraftingEur J Clin Microbiol Infect Dis199486103370

57 

L G Bode J A Kluytmans H F Wertheim D Bogaers C M V Grauls R Roosendaal Preventing surgical-site infections in nasal carriers of Staphylococcus aureusNew England J Med20103621917

58 

E Li J R Stanley The role of newer antibiotics in gastroenterologyGastroenterol Clin North Am199221361342

59 

S Gorbach Bacterial diarrhoea and its treatment.Lancet19873306137882

60 

C Ferreccio Glenn Morris J Valdivieso C Prenzel I Sotomayor V Drusano Efficacy of ciprofloxacin in the treatment of chronic typhoid carriers.J infect Dis19881571123544

61 

E Gotuzzo J G Guerra L Benavente J C Palomino C Carrillo J Lopera Use of norfloxacin to treat chronic typhoid carriersJ Infect Dis1988157612216

62 

F J Tedesco D Gordon W C Fortson Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitisAm J Gastroent1985801180718

63 

A T Axon P B Cotton Endoscopy and infectionGut198324111064

64 

J A Bianco M S Pepe C Higano F R Appelbaum G B Mcdonald J W Singer Prevalence of clinically relevant bacteremia after upper gastrointestinal endoscopy in bone marrow transplant recipients.Am J Med19908913440

65 

F Tam H Chow T Prindiville D Cornish T Haulk W Trudeau Bacterial peritonitis following esophageal injection sclerotherapy for variceal hemorrhageGastrointestinal Endoscopy19903621314

66 

H C Neu D Fleischer Antibiotic prophylaxis for GI endoscopyAm J gastroenterol1989841148891

67 

J A Bianco M S Pepe C Higano F R Appelbaum G B Mcdonald J W Singer Prevalence of clinically relevant bacteremia after upper gastrointestinal endoscopy in bone marrow transplant recipients.Am J Med199081113440

68 

H C Neu D Fleischer antibiotic prophylaxis before endoscopy. The American journal of gastroenterology1989841148891

69 

J O Lusins H Nakagawa Rationale for prophylactic antibiotics in neurosurgeryNeurosurgery198192142142

70 

M K Turel B Meshram V Rajshekhar Survey of Prophylactic use of Antibiotics among Indian NeurosurgeonsNeurology India20216961737

71 

R Dempsey R P Rapp B Young S Johnston P Tibbs Prophylactic parenteral antibiotics in clean neurosurgical procedures: a reviewJ Neurosurg1988691529

72 

C Armstrong ACOG Releases Guidelines on Antibiotic Prophylaxis for Gynecologic ProceduresAm Fam Physician20077571094

73 

A A Kamat L Brancazio M Gibson Wound infection in gynecologic surgeryInfect Dis obstetrics Gynecol200085-62304

74 

M Mcdonald E Grabsch C Marshall A Forbes SINGLE-VERSUS MULTIPLE-DOSE antimicrobial prophylaxis for major surgery: a systematic reviewAust New Zealand J Surg199868638895

75 

J A Mcgregor J I French E Makowski Single-dose cefotetan versus multidose cefoxitin for prophylaxis in cesarean section in high-risk patientsAm J Obstet Gynecol1986154495560

76 

J W Weinstein M Roe M Towns L Sanders J J Thorpe G R Corey Resistant Enterococci: A Prospective, Study of Prevalence, Incidence, and Factors Associated With Colonization in a University HospitalInfect Control Hospital Epidemiol19961713641

77 

R N Jones W Wojeski J Bakke C Porter M Searles Antibiotic prophylaxis of 1,036 patients undergoing elective surgical procedures. A prospective, randomized comparative trial of cefazolin, cefoxitin, and cefotaxime in a prepaid medical practiceAm J Surg198715343416

78 

E Declercq M Barger H J Cabral S R Evans M Kotelchuck C Simon Maternal outcomes associated with planned primary cesarean births compared with planned vaginal birthsObstet Gynecol2007109366977

79 

V Clifford A Daley Antibiotic prophylaxis in obstetric and gynaecological procedures: a reviewAustralian New Zealand J Obstet Gynaecol201252541221

80 

S L Achilles M F Reeves Prevention of infection after induced abortionContraception2011834295309

81 

F R Jacot C Poulin A P Bilodeau M Morin S Moreau F Gendron A five-year experience with second-trimester induced abortions: no increase in complication rate as compared to the first trimesterAm J obstet gynecol1993168263340

82 

P Levallois J E Rioux Prophylactic antibiotics for suction curettage abortion: results of a clinical controlled trial. Am J obstet Gynecol198815811005

83 

P Duff R C Park Antibiotic prophylaxis in vaginal hysterectomy: a reviewObstet Gynecol1980555193202

84 

V Tanos N Rojansky Prophylactic antibiotics in abdominal hysterectomyJ Am Coll Surg19941795593600

85 

D Sarlos L Kots N Stevanovic S Von Felten G Schär Robotic compared with conventional laparoscopic hysterectomy: a randomized controlled trialObstet Gynecol2012120360415



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Review Article


Article page

150-157


Authors Details

Mohamed Aamir Zuhaib S, Sneha Ann John, Sunitha M, Vineet Chandy


Article History

Received : 01-07-2022

Accepted : 15-07-2022


Article Metrics


View Article As

 


Downlaod Files